Impact of COVID-19 on Occupational Dermato-allergology Consultations of Health Peronnel

NCT06237010 | Completed

• 1 other identifier: ÉPIDERMAPS-COVID-19
• Study Type: observational
• Target: 341
• Locations: 1 country
• Sites: 2

Brief Summary

Occupational dermatitis is the second most common occupational disease in Europe, with a notable prevalence among healthcare workers-approximately 20% of whom are affected. However, these figures may be underestimated due to underreporting. Despite the presumed scale of the problem, there is no recent European data providing real numbers. This study seeks to address the knowledge gap regarding the impact of the COVID-19 pandemic on occupational dermatitis within the healthcare workers population. EPIDERMAPS is a retrospective cohort study that analyzes data from two specialized centers in the Paris region. The primary goal is to assess changes in the proportion of dermatology-allergology consultations among healthcare workers before and after the COVID-19 pandemic. Secondary objectives include evaluating the pandemic's effect on occupational dermatoses incidences, attributed to increased PPE and hygiene products usage. The major focus will be on work-related allergic contact dermatitis, irritant contact dermatitis, contact urticaria, acne, and rosacea. The latter objective is to identify new allergens or contributing factors. Participants include active healthcare workers aged 18 or older who sought consultations for dermatological or dermatology-allergology related motifs between March 15, 2017, and March 15, 2023. Exclusions apply for patients who have consulted for other than dermatology-allergology related motif and those opposing to participate. Data will be stored, anonymized, and analyzed using EasyMedStat. Data collection is scheduled between March and December 2024. This research aims to offer insights into COVID-19's dermatologic and allergic effects on healthcare professionals, informing future preventive measures and enhanced care strategies.

Conditions

Dermatoses; Health Workers

Keywords

COVID-19; Dermatoses; Contact dermatitis; Occupational dermatitis

Outcome Measures

Primary Outcomes (1)

• Proportion of occupational dermato-allergology consultations

  Proportion of occupational dermato-allergology consultations

  Day 1

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who consulted for the first time between 15th march 2017 and 15th march 2023 for an occupational dermato-allergological problem and occupying a health personnel position.

You may qualify if:

• Patients who consulted for the first time between 15th march 2017 and 15th march 2023 for an occupational dermato-allergological problem ;
• Active subjects and occupying a health personnel position defined according to the Public Health Code ;
• Over 18 years old at the first consultation, with no upper limit
• Having not expressed their opposition to participate in the study.

You may not qualify if:

• Patients who consulted for an other problem than occupational dermato-allergological problem ;
• Patients who not consulted for the first time between 15th march 2017 and 15th march 2023.
• Patients without occupational activity the day of the first consultation
• Patients who opposite to participation in the study

Sponsors & Collaborators

• Centre Hospitalier Intercommunal Creteil: lead

Study Sites (2)

Centre Hospitalier Intercommunal de Créteil

Créteil, 94000, France

Location

Hôpital Hôtel Dieu

Paris, 75004, France

Location

MeSH Terms

Conditions

Skin Diseases; COVID-19; Dermatitis, Contact; Dermatitis, Occupational

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Dermatitis; Skin Diseases, Eczematous; Occupational Diseases

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 31, 2024
• First Posted: February 1, 2024
• Study Start: March 15, 2024
• Primary Completion: February 9, 2025
• Study Completion: February 9, 2025
• Last Updated: December 15, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

FR (2)